We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Feather Safety Razor

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

Rapid Hemostasis System Seals Gunshot Wounds

By HospiMedica International staff writers
Posted on 06 Sep 2017
Print article
Image: The XSTAT-30 device injects pellet-shaped sponges for hemostasis (Photo courtesy of RevMedx).
Image: The XSTAT-30 device injects pellet-shaped sponges for hemostasis (Photo courtesy of RevMedx).
A novel hemostatic device helps control severe, life-threatening bleeding from narrow entrance extremity injuries and junctional wounds in the groin.

The RevMedx (Wilsonville, OR, USA) XStat is a syringe-like applicator intended for the treatment of severe bleeding from bullet or knife wounds located in an arm or leg, and for wounds in junctional areas such as the groin or shoulder that are not amenable to tourniquet application. XStat is filled with compressed sponges coated with a hemostatic agent that expand once in contact with a liquid, rapidly filling a substantially larger volume. Besides helping to block blood flow, the sponges also provide a surface on which blood clots can begin to form. Since the sponges have to be eventually removed, each has a radiopaque marker.

Two applicator sizes are available, a 30 mm diameter applicator for wide wound tracks and a 12 mm diameter applicator for narrower ones. The XStat-30 applicator holds 92 tablet-sized mini-cellulose coated sponges that are capable of absorbing 570 ml blood. It includes with a sealed valve tip designed to prevent fluid ingress and to minimize the risk of premature sponge expansion; a telescoping handle mechanism allows the device to be stored in a shortened state. The slimmer XStat-12 applicator consists of a cylindrical applicator body with a frangible tip and a detachable plunger.

“Our mission is to reduce death and disability from traumatic bleeding injuries caused by war, violence or accidents,” said Andrew Barofsky, CEO of RevMedx. “The expansion of XSTAT’s indications accelerates fulfillment of this mission by providing first responders with an additional capability to treat penetrating injuries located in an arm, leg, shoulder, or groin.”

Related Links:
RevMedx


Print article

Channels

Surgical Techniques

view channel
Image: A minimally invasive diagnostic biomarker strategy has proven successful in detecting early esophageal cancer (Photo courtesy of Pexels)

Minimally Invasive Device Combined With Molecular Biomarkers Detects Early Esophageal Cancer

Esophageal cancer remains the sixth-most common cause of cancer death worldwide, claiming the lives of more than half a million people annually. Esophageal squamous cell carcinoma (ESCC) comprises 80%... Read more

Patient Care

view channel
Image: Future wearable health tech could measure gases released from skin (Photo courtesy of Pexels)

Wearable Health Tech Could Measure Gases Released From Skin to Monitor Metabolic Diseases

Most research on measuring human biomarkers, which are measures of a body’s health, rely on electrical signals to sense the chemicals excreted in sweat. But sensors that rely on perspiration often require... Read more

Health IT

view channel
Image: AI can reveal a patient`s heart health (Photo courtesy of Mayo Clinic)

AI Trained for Specific Vocal Biomarkers Could Accurately Predict Coronary Artery Disease

Earlier studies have examined the use of voice analysis for identifying voice markers associated with coronary artery disease (CAD) and heart failure. Other research groups have explored the use of similar... Read more
Copyright © 2000-2022 Globetech Media. All rights reserved.